Health Care/Hospital

Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate

* Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials * Cytiva provides FlexFactory™ bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market SHANGHAI, Nov. 16, 2020 /PRNewsw...

2020-11-16 14:00 1360

Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology

SAN FRANCISCO and SUZHOU, China, Nov. 16, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2020-11-16 08:00 5274

International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis

IDF marks World Diabetes Day and the International Year of the Nurse and Midwife by offering free accredited diabetes training BRUSSELS, Nov. 14, 2020 /PRNewswire/ -- This World Diabetes Day, the International Diabetes Federation (IDF) is calling for more nurses to be trained to help people livi...

2020-11-14 08:00 3563

The third CIIE concludes, $72.6 billion in intended deals for the coming year inked

SHANGHAI, Nov. 14, 2020 /PRNewswire/ -- Despite the global market uncertainties caused by the COVID-19 pandemic, the confidence and interest that foreign companies have in the Chinese market appear unchanged, with the value of tentative deals reached for one-year purchases of goods and services a...

2020-11-14 03:21 5120

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission, ELZONRIS will be the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, inEurope FLORENCE, Italy, Nov. 14...

2020-11-14 01:03 4011

FDI World Dental Federation: Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year

FDI World Dental Federation (FDI) releases new White Paper on antibiotic resistance to mark World Antimicrobial Awareness Week GENEVA and LONDON, Nov. 14, 2020 /PRNewswire/ -- One of the unintended consequences of the COVID-19 lockdowns inEngland earlier this year has been a 25 per cent increase...

2020-11-14 01:00 3797

The fourth CIIE begins taking stall reservations from exhibitors

SHANGHAI, Nov. 13, 2020 /PRNewswire/ -- Some exhibitors planning to attend the fourth China International Import Expo (CIIE) next year started to reserve their stalls onNov 8. This is the first time that the CIIE has offered such an option. Five dairy companies – Fonterra, Mille, Ausnutria, Yash...

2020-11-13 21:00 3862

AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting

VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire/ -- On November 13th, 2020, AlpVision is launching the "AlpVision COVID-19 Initiative" helping pharmaceutical companies to protect COVID-19 relevant medicines against counterfeiting.

2020-11-13 20:25 2791

Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer

STOCKHOLM, Nov. 13, 2020 /PRNewswire/ -- RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed article reports that the treatment with RhoVac's drug candidate ...

2020-11-13 17:53 2104

iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay

* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...

2020-11-13 16:29 1737

iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay

* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...

2020-11-13 15:18 1702

Indonesia's Government Sets Out to Rescue Microenterprises from the Pandemic Impact

* Nine million microenterprises have received the Banpres Produktif Usaha Mikro (Productive presidential aid for microenterprises) * Kredit Usaha Rakyat Super Mikro (Super-micro People's Business Credit) offered with an interest rate of 0% untilDecember 31 2020. JAKARTA, Indonesia, Nov. 17, 2...

2020-11-13 14:12 2253

Ascensia Diabetes Care Showcases The Crucial Support Nurses Provide People With Diabetes To Celebrate World Diabetes Day 2020

BASEL, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company and maker of the CONTOUR® range of blood glucose monitoring systems, is tomorrow celebrating the crucial role that nurses play in helping people manage their diabetes, as part of World...

2020-11-13 14:00 2544

Secure World launches "COVID19-Guard", a non-contact, walkthrough-type security solution.

* 2020 Pandemic, Korea's Mask mandate is being recognized * The rising cases in Europe calls for adopting a Korean-style guideline and strategies * K-Quarantine has become a role model as COVID-19 spreads in the world * It is recommended to set the technology and strategy standards by benc...

2020-11-13 13:44 1108

Supported by 23 Ministries and Institutions, the Ministry of Tourism and Creative Economy Holds 3K Protocol Simulation for National Tourism Destinations

LABUAN BAJO, Indonesia, Nov. 13, 2020 /PRNewswire/ -- The Ministry of Tourism and Creative Economy / the Tourism and Creative Economy Agency (Kemenparekraf), supported by 23 ministries and institutions, held a simulation of the3K protocol (health, security, and safety) for national tourism destin...

2020-11-13 12:09 3502

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 11:07 2003

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:34 1722

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:32 1848

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:29 1798

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:26 2008
1 ... 398399400401402403404 ... 554